France's Servier eyes €500 mn global sales from India drug tie-ups
Servier, which partners with local contract manufacturers, announced a €15 million investment to set up a platform called Gatinn to develop single-pill combinations for cardiometabolic and venous diseases in India
Servier, which partners with local contract manufacturers, announced a €15 million investment to set up a platform called Gatinn to develop single-pill combinations for cardiometabolic and venous diseases in India
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
